二甲美西宁通过影响血管生成来抑制黑色素瘤的迁移和转移
Zhaoxiang Li1, Qi Zhang1, Xinyuan Zhang1
1Department of Immunology and Pathogenic Biology, Yanbian University Medical College, Yanji, China.
Phytotherapy research : PTR
|November 20, 2023
概括
乙甲胺素 (DHA) 通过向瘤血管生成来抑制黑色素瘤转移. 这项研究阐明了DHA如何抑制关键的血管新生通路,为黑色素瘤治疗提供了潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 瘤血管新生对于转移至关重要,提供营养并促进传播.
- 二甲胺素 (DHA) 显示出作为抗血管原体的潜力,但其在黑色素瘤中的机制尚不清楚.
研究的目的:
- 研究DHA调节黑色素瘤进展和转移的机制.
- 阐明血管新生在DHA抗黑色素瘤作用中的作用.
主要方法:
- 生物信息分析以关联血管生成和黑色素瘤转移.
- 在体外 (B16F10,A375,HUVECs) 和体内 (老鼠转移模型) 实验.
- 基因组丰富分析 (GSEA),CD31和VEGFR2表达的评估,管状形成试验和非向的代谢学.
主要成果:
- 黑色素瘤转移与血管生成有很强的相关性.
- 在小鼠中,DHA显著降低了黑色素瘤结节和肺重量,抑制了CD31的表达.
- DHA抑制了VEGFR2表达,管体形成和HUVEC迁移,识别了HIF-1α/VEGF和PI3K/ATK/mTOR通路.
结论:
- DHA通过向和抑制关键的血管新生通路来抑制黑色素瘤的侵袭和转移.
- 这些发现支持DHA作为治疗黑色素瘤治疗的治疗剂的潜力.
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K


